We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ondine Biomed | LSE:OBP | London | Ordinary Share | CA68234M1068 | COM SHS NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMOBP
Circ re: Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company") Publication of Information Circular and Mail Out of Financial Statements, MD&A and Shareholder Meeting Materials
FOR: ONDINE BIOPHARMA CORPORATION
TSX, AIM SYMBOL: OBP
May 20, 2010
Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company") Publication of Information Circular and Mail
Out of Financial Statements, MD&A and Shareholder Meeting Materials
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 20, 2010) - Ondine Biopharma (TSX:OBP)(AIM:OBP) announces that,
in accordance with regulatory requirements, it has mailed out its Financial Statements and Management
Discussion and Analysis (MD&A) for the year ended December 31, 2009 as well as its Information Circular, Notice
of Meeting and related proxy materials on May 19, 2010, in connection with the Company's annual general and
special meeting to be held on Thursday, June 17, 2010 at 10:00 A.M. (the "Meeting") at the Company's office at
910-1100 Melville Street, Vancouver, British Columbia, Canada. Copies of these documents are available during
normal business hours on weekdays (except Saturdays, Sundays and public holidays) free of charge from the
Company's office at 910-1100 Melville Street, Vancouver, British Columbia, Canada. In addition, these documents
are available on the SEDAR website at www.sedar.com and on the Company's website at www.ondinebiopharma.com.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Ondine Biopharma Corporation
Carolyn Cross
Chairman and Chief Executive Officer
(604) 669-0555
ccross@ondinebiopharma.com
www.ondinebiopharma.com
OR
Canaccord Genuity Limited
Ryan Gaffney
Nominated Adviser
+4420 7050 6500
Ondine Biopharma Corporation
1 Year Ondine Biomed Chart |
1 Month Ondine Biomed Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
